USPTO Assignments on the Web

	United States Patent and Trademark Office
	Home\|Site Index\|Search\|Guides\|Contacts\|eBusiness\|eBiz alerts\|News\|Help

Patent Assignment Details

NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:	067203/0398			Pages:	61
		Recorded:	04/23/2024
Attorney Dkt #:	697130/22
Conveyance:	ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).

Total properties: 30

Patent #:	7276250	Issue Dt:	10/02/2007	Application #:	10189932	Filing Dt:	07/03/2002
Publication #:	US20030129230	Pub Dt:	07/10/2003
Title:	SUSTAINED RELEASE FORMULATIONS OF OXYMORPHONE

Patent #:	9820982	Issue Dt:	11/21/2017	Application #:	10190192	Filing Dt:	07/03/2002
Publication #:	US20030157167	Pub Dt:	08/21/2003
Title:	Oxymorphone controlled release formulations

Patent #:	7214387	Issue Dt:	05/08/2007	Application #:	10630239	Filing Dt:	07/30/2003
Publication #:	US20040109891	Pub Dt:	06/10/2004
Title:	SUSTAINED RELEASE FORMULATIONS OF METFORMIN

Patent #:	7229636	Issue Dt:	06/12/2007	Application #:	10787385	Filing Dt:	02/26/2004
Title:	CYANOCOBALAMIN LOW VISCOSITY AQUEOUS FORMULATIONS FOR INTRANASAL DELIVERY

Patent #:	7404489	Issue Dt:	07/29/2008	Application #:	10814399	Filing Dt:	03/31/2004
Title:	CYANOCOBALAMIN LOW VISCOSITY AQUEOUS FORMULATIONS FOR INTRANASAL DELIVERY

Patent #:	8389008	Issue Dt:	03/05/2013	Application #:	10943356	Filing Dt:	09/17/2004
Publication #:	US20050112201	Pub Dt:	05/26/2005
Title:	DELAYED RELEASE DOSAGE FORMS

Patent #:	8329216	Issue Dt:	12/11/2012	Application #:	11427438	Filing Dt:	06/29/2006
Publication #:	US20070098794	Pub Dt:	05/03/2007
Title:	OXYMORPHONE CONTROLLED RELEASE FORMULATIONS

Patent #:	8771732	Issue Dt:	07/08/2014	Application #:	11509347	Filing Dt:	08/24/2006
Publication #:	US20070048376	Pub Dt:	03/01/2007
Title:	Sustained release formulations of nalbuphine

Patent #:	8309122	Issue Dt:	11/13/2012	Application #:	11680432	Filing Dt:	02/28/2007
Publication #:	US20070134328	Pub Dt:	06/14/2007
Title:	OXYMORPHONE CONTROLLED RELEASE FORMULATIONS

Patent #:	7879349	Issue Dt:	02/01/2011	Application #:	12079875	Filing Dt:	03/27/2008
Publication #:	US20080182817	Pub Dt:	07/31/2008
Title:	CYANOCOBALAMIN LOW VISCOSITY AQUEOUS FORMULATIONS FOR INTRANASAL DELIVERY

Patent #:	8003353	Issue Dt:	08/23/2011	Application #:	12142240	Filing Dt:	06/19/2008
Publication #:	US20080255067	Pub Dt:	10/16/2008
Title:	CYANOCOBALAMIN LOW VISCOSITY AQUEOUS FORMULATIONS FOR INTRANASAL DELIVERY

Patent #:	8394812	Issue Dt:	03/12/2013	Application #:	12154496	Filing Dt:	05/23/2008
Publication #:	US20090030026	Pub Dt:	01/29/2009
Title:	SUSTAINED RELEASE FORMULATIONS OF NALBUPHINE

Patent #:	9186374	Issue Dt:	11/17/2015	Application #:	12618099	Filing Dt:	11/13/2009
Publication #:	US20100210580	Pub Dt:	08/19/2010
Title:	VITAMIN B12 NASAL SPRAY AND METHOD OF USE

Patent #:	8808737	Issue Dt:	08/19/2014	Application #:	12716973	Filing Dt:	03/03/2010
Publication #:	US20100151027	Pub Dt:	06/17/2010
Title:	METHOD OF TREATING PAIN UTILIZING CONTROLLED RELEASE OXYMORPHONE PHARMACEUTICAL COMPOSITIONS AND INSTRUCTION ON DOSING FOR RENAL IMPAIRMENT

Patent #:	8940714	Issue Dt:	01/27/2015	Application #:	13189061	Filing Dt:	07/22/2011
Publication #:	US20120190640	Pub Dt:	07/26/2012
Title:	CYANOCOBALAMIN LOW VISCOSITY AQUEOUS FORMULATIONS FOR INTRANASAL DELIVERY

Patent #:	8765175	Issue Dt:	07/01/2014	Application #:	13773136	Filing Dt:	02/21/2013
Publication #:	US20130164350	Pub Dt:	06/27/2013
Title:	SUSTAINED RELEASE FORMULATION OF NALBUPHINE

Patent #:	8969368	Issue Dt:	03/03/2015	Application #:	14091399	Filing Dt:	11/27/2013
Publication #:	US20140088132	Pub Dt:	03/27/2014
Title:	CRYSTALLINE, ANHYDROUS FORMS OF OXYMORPHONE HYDROCHLORIDE

Patent #:	9351938	Issue Dt:	05/31/2016	Application #:	14290413	Filing Dt:	05/29/2014
Publication #:	US20140271852	Pub Dt:	09/18/2014
Title:	SUSTAINED RELEASE FORMULATION OF NALBUPHINE

Patent #:	9186330	Issue Dt:	11/17/2015	Application #:	14319833	Filing Dt:	06/30/2014
Publication #:	US20140315937	Pub Dt:	10/23/2014
Title:	SUSTAINED RELEASE FORMULATION OF NALBUPHINE

Patent #:	9789103	Issue Dt:	10/17/2017	Application #:	14336753	Filing Dt:	07/21/2014
Publication #:	US20140329847	Pub Dt:	11/06/2014
Title:	METHOD OF TREATING PAIN UTILIZING CONTROLLED RELEASE OXYMORPHONE PHARMACEUTICAL COMPOSITIONS AND INSTRUCTION ON DOSING FOR RENAL IMPAIRMENT

Patent #:	9415007	Issue Dt:	08/16/2016	Application #:	14485228	Filing Dt:	09/12/2014
Publication #:	US20150004198	Pub Dt:	01/01/2015
Title:	CYANOCOBALAMIN LOW VISCOSITY AQUEOUS FORMULATIONS FOR INTRANASAL DELIVERY

Patent #:	9440986	Issue Dt:	09/13/2016	Application #:	14613421	Filing Dt:	02/04/2015
Publication #:	US20150148368	Pub Dt:	05/28/2015
Title:	CRYSTALLINE, ANHYDROUS FORMS OF OXYMORPHONE HYDROCHLORIDE

Patent #:	10251908	Issue Dt:	04/09/2019	Application #:	14738417	Filing Dt:	06/12/2015
Publication #:	US20150272876	Pub Dt:	10/01/2015
Title:	VITAMIN B12 NASAL SPRAY AND METHOD OF USE

Patent #:	10052344	Issue Dt:	08/21/2018	Application #:	14878430	Filing Dt:	10/08/2015
Publication #:	US20160022726	Pub Dt:	01/28/2016
Title:	VITAMIN B12 NASAL SPRAY AND METHOD OF USE

Patent #:	9926328	Issue Dt:	03/27/2018	Application #:	15263175	Filing Dt:	09/12/2016
Publication #:	US20170137433	Pub Dt:	05/18/2017
Title:	CRYSTALLINE, ANHYDROUS FORMS OF OXYMORPHONE HYDROCHLORIDE

Patent #:	10172798	Issue Dt:	01/08/2019	Application #:	15658234	Filing Dt:	07/24/2017
Publication #:	US20180042852	Pub Dt:	02/15/2018
Title:	SUSTAINED RELEASE FORMULATION OF NALBUPHINE

Patent #:	11389443	Issue Dt:	07/19/2022	Application #:	15785080	Filing Dt:	10/16/2017
Publication #:	US20180098985	Pub Dt:	04/12/2018
Title:	METHOD OF TREATING PAIN UTILIZING CONTROLLED RELEASE OXYMORPHONE PHARMACEUTICAL COMPOSITIONS AND INSTRUCTION ON DOSING FOR RENAL IMPAIRMENT

Patent #:	10406106	Issue Dt:	09/10/2019	Application #:	16198143	Filing Dt:	11/21/2018
Publication #:	US20190117576	Pub Dt:	04/25/2019
Title:	SUSTAINED RELEASE FORMULATIONS OF NALBUPHINE

Patent #:	NONE	Issue Dt:		Application #:	17035453	Filing Dt:	09/28/2020
Publication #:	US20210008063	Pub Dt:	01/14/2021
Title:	OXYMORPHONE CONTROLLED RELEASE COMPOSITIONS

Patent #:	NONE	Issue Dt:		Application #:	17838636	Filing Dt:	06/13/2022
Publication #:	US20220313688	Pub Dt:	10/06/2022
Title:	METHOD OF TREATING PAIN UTILIZING CONTROLLED RELEASE OXYMORPHONE PHARMACEUTICAL COMPOSITIONS AND INSTRUCTION ON DOSING FOR RENAL IMPAIRMENT

Assignor

Exec Dt:

04/23/2024

Assignee

1400 ATWATER DRIVE

MALVERN, PENNSYLVANIA 19355

Correspondence name and address
	MS. MONIQUE L RIBANDO
	SKADDEN, ARPS, SLATE, MEAGHER & FLOM LLP
	ONE MANHATTAN WEST
	NEW YORK, NY 10001-8602

Search Results as of: 05/22/2024 03:43 AM

If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6

Web interface last modified: August 25, 2017 v.2.6